Polaryx Therapeutics, Inc. (PLYX) — S-1 Filings
All S-1 filings from Polaryx Therapeutics, Inc.. Browse 1 IPO Filing reports with AI-powered summaries and risk analysis.
S-1 Filings (1)
-
Polaryx Targets Nasdaq Listing, Advances PLX-200 for Rare LSDs
— Nov 21, 2025 Risk: high
Polaryx Therapeutics, Inc. (PLYX) is a clinical-stage biotechnology company focused on rare pediatric lysosomal storage disorders (LSDs), pursuing a direct list
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX